| 國立成功大學 |
2023 |
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized
|
Chiu, Y.-F.;Liu, T.-W.;Shan, Y.-S.;Chen, J.-S.;Li, C.-P.;Ho, C.-L.;Hsieh, R.-K.;Hwang, T.-L.;Chen, L.-T.;Ch'ang, H.-J. |
| 臺大學術典藏 |
2022-08-19T00:20:57Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Cheng A.-L.; Meng R.; Chao Y.; Hsieh T.-Y.; Huang W.-T.; Hwang W.-S.; Yu C.-W.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; CHIUN HSU |
| 臺大學術典藏 |
2022-06-27T07:07:55Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; CHONG-JEN YU; Chang W.-C.; Kuo H.-P.; Yu C.-T.; Lin Z.-Z.; Kao W.-Y. |
| 臺大學術典藏 |
2022-06-10T06:11:15Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y. |
| 臺大學術典藏 |
2022-06-10T06:11:13Z |
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting
|
Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN; Chao T.-Y. |
| 臺大學術典藏 |
2022-04-28T08:06:32Z |
The law of Yin and Yang for controlled drugs ecosystem: Maximal analgesia with minimal abuse
|
Sun W.-Z.; Hsieh Y.-J.; Lin C.-S.; YEUR-HUR LAI; Chien S.-C.; Wang C.-W.; Hsieh R.-K.; Taiwan Pain Forum |
| 臺大學術典藏 |
2022-01-24T09:32:34Z |
Gene rearrangement of cutaneous T-cell lymphoma.
|
Fan F.S.; Lin S.H.; Tzeng C.H.; Chuang M.W.; Yang J.H.; Liu J.H.; Hsieh R.K.; CHUN-JEN LIU; Liu J.M.; Chen M.S. |
| 臺大學術典藏 |
2022-01-24T09:32:34Z |
Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy
|
Tzeng C.-H.; Chen P.-M.; Chuang M.-W.; Liu J.-H.; Hsieh R.-K.; CHUN-JEN LIU; Fan S.; Chen K.Y.; Yung C.-H.; Wang S.-Y.; Chau W.-K.; Ching K.-N. |
| 臺大學術典藏 |
2022-01-24T09:32:33Z |
Remission induction of ANLL with low dose cytosine arabinoside combined with retinoic acid.
|
Chen P.M.; Hsieh R.K.; Chuang M.W.; Liu J.H.; Fan S.; CHUN-JEN LIU; Tzeng C.H. |
| 臺大學術典藏 |
2022-01-24T09:32:33Z |
Complications of bone marrow transplantation in Chinese.
|
Chen P.M.; Fan S.; CHUN-JEN LIU; Hsieh R.K.; Liu J.H.; Chuang M.W.; Liu R.S.; Tzeng C.H. |
| 臺大學術典藏 |
2021-09-01T02:02:42Z |
Weekly CAF chemotherapy for advanced breast cancer patients
|
Hwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:19Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.; Yeh K.H.; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:10Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; Yeh K.H.; Kao W.Y.; Chen L.T.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:08Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; Yeh K.-H.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu C.; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-11T03:46:52Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y. |
| 臺大學術典藏 |
2021-08-11T03:46:50Z |
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting
|
Ho C.-L.; Su W.-C.; Hsieh R.-K.; ZHONG-ZHE LIN; Chao T.-Y. |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Hong R.-L.; CHING-HUNG LIN; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-05-03T02:20:56Z |
Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy—a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines
|
Yu S.; Burke T.A.; Chan A.; Kim H.-K.; Hsieh R.K.; Hu X.; JIN-TUNG LIANG; Ba?os A.; Spiteri C.; Keefe D.M.K. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Ruey-Long Hong;Lin C.-H.;Chao T.-Y.;Kao W.-Y.;Wang C.-H.;Hsieh R.K.;Hwang W.-S.; RUEY-LONG HONG; Lin C.-H.; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-03-05T06:07:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; MING-CHU CHANG; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-02-05T06:29:30Z |
Rapid and sensitive detection of CALR exon 9 mutations using high-resolution melting analysis
|
Lim K.-H.; Lin H.-C.; Chen C.G.S.; Wang W.-T.; Chang Y.-C.; Chiang Y.-H.; Lin C.-S.; Su N.-W.; Su Y.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU |
| 臺大學術典藏 |
2021-02-05T06:29:29Z |
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis
|
Lim K.-H.; Chang Y.-C.; Gon-Shen Chen C.; Lin H.-C.; Wang W.-T.; Chiang Y.-H.; Cheng H.-I.; Su N.-W.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; Kuo Y.-Y.; WEN-CHIEN CHOU |
| 臺大學術典藏 |
2021-02-05T06:29:22Z |
Germline variations at JAK2, TERT, HBS1L-MYB and MECOM and the risk of myeloproliferative neoplasms in Taiwanese population
|
Chiang Y.-H.;Chang Y.-C.;Lin H.-C.;Huang L.;Cheng C.-C.;Wang W.-T.;Cheng H.-I.;Su N.-W.;Chen C.G.;Lin J.;Chang Y.-F.;Chang M.-C.;Hsieh R.-K.;Wen-Chien Chou;Lim K.-H.;Kuo Y.-Y.; Chiang Y.-H.; Chang Y.-C.; Lin H.-C.; Huang L.; Cheng C.-C.; Wang W.-T.; Cheng H.-I.; Su N.-W.; Chen C.G.; Lin J.; Chang Y.-F.; Chang M.-C.; Hsieh R.-K.; WEN-CHIEN CHOU; Lim K.-H.; Kuo Y.-Y. |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao Y.;Kun-Huei Yeh;Chang C.J.;Chen L.T.;Chao T.Y.;Wu M.F.;Chang C.S.;Chang J.Y.;Chung C.Y.;Kao W.Y.;Hsieh R.K.;Cheng A.L.; Chao Y.; KUN-HUEI YEH; Chang C.J.; Chen L.T.; Chao T.Y.; Wu M.F.; Chang C.S.; Chang J.Y.; Chung C.Y.; Kao W.Y.; Hsieh R.K.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:46Z |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao Y.;Li C.P.;Chao T.Y.;Su W.C.;Hsieh R.K.;Wu M.F.;Kun-Huei Yeh;Kao W.Y.;Chen L.T.;Cheng A.L.; Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; KUN-HUEI YEH; Kao W.Y.; Chen L.T.; Cheng A.L. |
| 臺大學術典藏 |
2021-01-28T01:06:41Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen J.-S.;Chao Y.;Hsieh R.-K.;Cheng A.-L.;Chen P.-M.;Chiou T.-J.;Chao T.-Y.;Kun-Huei Yeh;Chen L.-T.;Whang-Peng J.; Chen J.-S.; Chao Y.; Hsieh R.-K.; Cheng A.-L.; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; KUN-HUEI YEH; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: A multicenter prospective Phase II trial
|
Hsieh J.C.; Hsu C.-L.; Ng S.-H.; Wang C.-H.; Lee K.-D.; Lu C.-H.; Chang Y.-F.; Hsieh R.-K.; KUN-HUEI YEH; Hsiao C.-H.; Chen S.-Y.; Shiau C.-Y.; Wang H.-M. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need
|
Rau K.-M.;Rau K.-M.;Shun S.-C.;Chiou T.-J.;Lu C.-H.;Lu C.-H.;Ko W.-H.;Ko W.-H.;Lee M.-Y.;Huang W.-T.;Kun-Huei Yeh;Chang C.-S.;Chang C.-S.;Hsieh R.-K.; Rau K.-M.; Rau K.-M.; Shun S.-C.; Chiou T.-J.; Lu C.-H.; Lu C.-H.; Ko W.-H.; Ko W.-H.; Lee M.-Y.; Huang W.-T.; KUN-HUEI YEH; Chang C.-S.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2021-01-15T03:47:00Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 國立成功大學 |
2021 |
High expression of kr�ppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, S.-L.;Shan, Y.-S.;Hsiao, C.-F.;Liu, T.-W.;Chen, J.-S.;Ho, C.-L.;Chou, W.-C.;Hsieh, R.-K.;Chen, L.-T.;Ch'ang, H.-J. |
| 臺大學術典藏 |
2020-11-13T07:56:51Z |
A nationwide survey of fatigue in cancer patients in Taiwan: An unmet need
|
Huang W.-T.; Lee M.-Y.; Ko W.-H.; Ko W.-H.; Lu C.-H.; Lu C.-H.; Chiou T.-J.; SHIOW-CHING SHUN; Rau K.-M.; Rau K.-M.; Rau K.-M.;Rau K.-M.;Shiow-Ching Shun;Chiou T.-J.;Lu C.-H.;Lu C.-H.;Ko W.-H.;Ko W.-H.;Lee M.-Y.;Huang W.-T.;Yeh K.-H.;Chang C.-S.;Chang C.-S.;Hsieh R.-K.; Yeh K.-H.; Chang C.-S.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-07-09T02:57:03Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
CHIH-WEI YU; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; Hsu C. |
| 臺大學術典藏 |
2020-05-26T09:27:22Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Kao W.-Y.;Lin Z.-Z;Yu C.-T;Kuo H.-P;Chang W.-C;Yu C.-J;Chung C.-Y;Ho M.-L;Wang J.-L;Huang M.-S;Chen C.-H;Chen H.-C;Hsia T.-C;Tsao C.-J;Su W.-C;Lai R.-S;Chu N.-M;Hsieh R.-K;Lin M.-C;Chang G.-C;Chen Y.-M;Chih-Hsin Yang;Perng R.-P; Perng R.-P; CHIH-HSIN YANG; Chen Y.-M; Chang G.-C; Lin M.-C; Hsieh R.-K; Chu N.-M; Lai R.-S; Su W.-C; Tsao C.-J; Hsia T.-C; Chen H.-C; Chen C.-H; Huang M.-S; Wang J.-L; Ho M.-L; Chung C.-Y; Yu C.-J; Chang W.-C; Kuo H.-P; Yu C.-T; Lin Z.-Z; Kao W.-Y. |
| 臺大學術典藏 |
2020-05-26T09:26:49Z |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial
|
Lux-Lung 5 Investigators;Serwatowski P;Kazarnowicz A;Jaskiewicz P;Palomino O.L.M;Pantigoso W.R;Barreda R.L.A;S?nchez J.F.S;Gans S;Herder G;Dingemans A.-M;Stigt J;Aerts J;Baca O.P;Luna G.A;Perez J.L.G;Delgado F.G;Cruciani G;Ceresoli G.L;Platania M;Milandri C;Gridelli C;Bearz A;Bidoli P;Migliorino M.R;Stemmer S;Gottfried M;Onn A;Nagarkar R.V;Dadhich H;Sharma L;Venkatesan S;Jain M;Prabhash K;Sarosi V;Strausz J;Tehenes S;Mark Z;Wiewrodt R;Dickgreber N;Huber R;Von Pawel J;Laack E;Keilholz U;Faehling M;Wehler T;Thomas M;Coudert B;Rotarski M;Gervais R;Fournel P;Bennouna J;Planchard D;Perol M;Sibilot D.M;Zalcman G;Chouaid C;Cadranel J;Alanko T;Riska H;Zadra C.A;Garicochea B;Zereu M;Lu S;Zhang Y;Huang J;Feng J;Qin S;Cheng Y;Liu X;Wu Y;Lin X;Thropay J;Meza L;Gurtler J;Summers Y;Upadhyay S;Brown E;Talbot T;Toy E;Spicer J;Popat S;Mitra S;Shah R;Polishchuk I;Bondarenko I;Ponomarova O;Popovych O;Vinnyk Y;Hsieh R.-K;Ho C.-L;Huang M.-S;Su W.-C;Tsao T.C.-Y;Chang G.-C;Tsai Y.-H;Chen Y.-M;Hsia T.-C;Yang C.-H;Kim Y.-C;Han J.-Y;Kim J.-H;Park K;Kim S.-W;Kim D.-W;Felip E;Cobo M;Lianes P;Campelo R.G;Camps C;Larriba J.L.G;Garrido P;Ragulin Y;Orlov S;Karaseva N;Lubennikov V;Jassem J;Szczesna A;Huang C;Wang J;Zhou C;Vercauter P;Delval L;Lambrechts M;Galdermans D;Carestia L;Bustin F;Humblet Y;Greil R;Mainwaring P;Crombie C;Underhill C;Parente P;Mclachlan S.-A;Richardet M;Blajman C;Zarba J.J;Recondo G;Martin C.M;Bagnes C;Planchard D;Chand V.K;Wang B;Zhou C;Wiewrodt R;Vinnyk Y;Strausz J;Lu S;Liu X;Kim D.-W;Grossi F;Feng J.-F;De Marinis F;Chouaid C;Chen Y.-M;Bennouna J;Kim J.-H;Park K;Chih-Hsin Yang;Schuler M; Zadra C.A; Riska H; Alanko T; Cadranel J; Chouaid C; Zalcman G; Sibilot D.M; Perol M; Planchard D; Bennouna J; Fournel P; Gervais R; Rotarski M; Coudert B; Thomas M; Wehler T; Faehling M; Keilholz U; Laack E; Von Pawel J; Huber R; Dickgreber N; Wiewrodt R; Mark Z; Tehenes S; Strausz J; Sarosi V; Prabhash K; Jain M; Venkatesan S; Sharma L; Dadhich H; Nagarkar R.V; Onn A; Gottfried M; Stemmer S; Migliorino M.R; Bidoli P; Bearz A; Gridelli C; Milandri C; Platania M; Ceresoli G.L; Cruciani G; Delgado F.G; Perez J.L.G; Luna G.A; Baca O.P; Aerts J; Stigt J; Dingemans A.-M; Herder G; Gans S; Sánchez J.F.S; Barreda R.L.A; Pantigoso W.R; Palomino O.L.M; Jaskiewicz P; Kazarnowicz A; Serwatowski P; Szczesna A; Jassem J; Lubennikov V; Karaseva N; Orlov S; Ragulin Y; Garrido P; Larriba J.L.G; Camps C; Campelo R.G; Lianes P; Cobo M; Felip E; Kim D.-W; Kim S.-W; Park K; Kim J.-H; Han J.-Y; Kim Y.-C; Yang C.-H; Hsia T.-C; Chen Y.-M; Tsai Y.-H; Chang G.-C; Tsao T.C.-Y; Su W.-C; Huang M.-S; Ho C.-L; Hsieh R.-K; Vinnyk Y; Popovych O; Ponomarova O; Bondarenko I; Polishchuk I; Shah R; Mitra S; Popat S; Spicer J; Toy E; Talbot T; Brown E; Upadhyay S; Summers Y; Gurtler J; Meza L; Thropay J; LUX-Lung 5 Investigators; Schuler M; CHIH-HSIN YANG; Park K; Kim J.-H; Bennouna J; Chen Y.-M; Chouaid C; De Marinis F; Feng J.-F; Grossi F; Kim D.-W; Liu X; Lu S; Strausz J; Vinnyk Y; Wiewrodt R; Zhou C; Wang B; Chand V.K; Planchard D; Bagnes C; Martin C.M; Recondo G; Zarba J.J; Blajman C; Richardet M; McLachlan S.-A; Parente P; Underhill C; Crombie C; Mainwaring P; Greil R; Humblet Y; Bustin F; Carestia L; Galdermans D; Lambrechts M; Delval L; Vercauter P; Zhou C; Wang J; Huang C; Lin X; Wu Y; Liu X; Cheng Y; Qin S; Feng J; Huang J; Zhang Y; Lu S; Zereu M; Garicochea B |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; CHIH-HUNG HSU; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Ch'Ang H.-J. ;Lin Y.-L. ;Wang H.-P. ;Chiu Y.-F. ;Chang M.-C. ;Chih-Hung Hsu ;Tien Y.-W. ;Chen J.-S. ;Hsieh R.-K. ;Lin P.-W. ;Shan Y.-S. ;Cheng A.-L. ;Chang J.-Y. ;Whang-Peng J. ;Hwang T.-L. ;Chen L.-T. |
| 臺大學術典藏 |
2020-04-10T12:51:14Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Chiun Hsu;Yang T.-S.;Huo T.-I.;Hsieh R.-K.;Yu C.-W.;Hwang W.-S.;Hsieh T.-Y.;Huang W.-T.;Chao Y.;Meng R.;Cheng A.-L.; Chiun Hsu; Yang T.-S.; Huo T.-I.; Hsieh R.-K.; Yu C.-W.; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:15:58Z |
Impact of Undertreatment of Cancer Pain With Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan
|
Shen W.-C.;Chen J.-S.;Yu-Yun Shao;Lee K.-D.;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Liao Y.-M.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Chou W.-C.;Hsieh R.-K.; Shen W.-C.; Chen J.-S.; YU-YUN SHAO; Lee K.-D.; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Liao Y.-M.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Chou W.-C.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou W.-C.;Chen J.-S.;Hung C.-Y.;Lu C.-H.;Yu-Yun Shao;Chiou T.-J.;Sung Y.-C.;Rau K.-M.;Yen C.-J.;Yeh S.-P.;Liu T.-C.;Wu M.-F.;Lee M.-Y.;Yu M.-S.;Hwang W.-L.;Lai P.-Y.;Chang C.-S.;Hsieh R.-K.; Chou W.-C.; Chen J.-S.; Hung C.-Y.; Lu C.-H.; YU-YUN SHAO; Chiou T.-J.; Sung Y.-C.; Rau K.-M.; Yen C.-J.; Yeh S.-P.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S.; Hwang W.-L.; Lai P.-Y.; Chang C.-S.; Hsieh R.-K. |
| 臺大學術典藏 |
2020-04-10T12:15:55Z |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Hwang W.-L.; Liu T.-C.; Yu M.-S.; Sung Y.-C.; Lee K.-D.; Lai P.-Y.; Hsieh R.-K.; Lee M.-Y.; Chiou T.-J.; Yeh S.-P.; Chen J.-S.; Chang C.-S.; Cho S.-F.;Rau K.-M.;Yu-Yun Shao;Yen C.-J.;Wu M.-F.;Chen J.-S.;Chang C.-S.;Yeh S.-P.;Chiou T.-J.;Hsieh R.-K.;Lee M.-Y.;Sung Y.-C.;Lee K.-D.;Lai P.-Y.;Yu M.-S.;Hwang W.-L.;Liu T.-C.; Cho S.-F.; Rau K.-M.; YU-YUN SHAO; Yen C.-J.; Wu M.-F. |
| 臺大學術典藏 |
2020-04-10T12:15:52Z |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Hwang W.-L.; Chiou T.-J.; Lai P.-Y.; Yen C.-J.; Lin J.; Hsieh R.-K.; Chen J.-S.; Lee K.-D.; Rau K.-M.; YU-YUN SHAO; Sung Y.-C.; Yeh S.-P.; Chang C.-S.; Liu T.-C.; Wu M.-F.; Lee M.-Y.; Yu M.-S. |
| 臺大學術典藏 |
2020-03-23T07:19:19Z |
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
|
Hsieh R.K.; Vuylsteke P.; CHIUN-SHENG HUANG; Aktas B.; Kim S.-B.; Jackisch C.; Smith I.; Azim H.A.;Agbor-Tarh D.;Bradbury I.;Dinh P.;Baselga J.;Di Cosimo S.;Greger Jr. J.G.;Smith I.;Jackisch C.;Kim S.-B.;Aktas B.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.K.;Dreosti L.;Eidtmann H.;Piccart M.;De Azambuja E.; Azim H.A.; Agbor-Tarh D.; Bradbury I.; Dinh P.; Baselga J.; Di Cosimo S.; Greger Jr. J.G.; De Azambuja E.; Piccart M.; Eidtmann H.; Dreosti L. |
| 臺大學術典藏 |
2020-03-23T07:19:13Z |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
Xu B.; Boyle F.; Smith I.; Jackisch C.; Lang I.; Untch M.; Swaby R.F.; Di Cosimo S.; Holmes E.; Piccart-Gebhart M.; Holmes A.P.; De Azambuja E.;Holmes A.P.;Piccart-Gebhart M.;Holmes E.;Di Cosimo S.;Swaby R.F.;Untch M.;Jackisch C.;Lang I.;Smith I.;Boyle F.;Xu B.;Barrios C.H.;Perez E.A.;Azim H.A.;Kim S.-B.;Kuemmel S.;Chiun-Sheng Huang;Vuylsteke P.;Hsieh R.-K.;Gorbunova V.;Eniu A.;Dreosti L.;Tavartkiladze N.;Gelber R.D.;Eidtmann H.;Baselga J.; De Azambuja E.; Barrios C.H.; Perez E.A.; Azim H.A.; Kim S.-B.; Kuemmel S.; CHIUN-SHENG HUANG; Vuylsteke P.; Hsieh R.-K.; Gorbunova V.; Eniu A.; Dreosti L.; Tavartkiladze N.; Gelber R.D.; Eidtmann H.; Baselga J. |
| 臺大學術典藏 |
2020-02-20T06:53:13Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.; Shan Y.-S.; Cheng A.-L.; Lin P.-W.; Chen J.-S.; Hsieh R.-K.; YU-WEN TIEN; Ch'Ang H.-J.;Lin Y.-L.;Wang H.-P.;Chiu Y.-F.;Chang M.-C.;Hsu C.-H.;Yu-Wen Tien;Chen J.-S.;Hsieh R.-K.;Lin P.-W.;Shan Y.-S.;Cheng A.-L.;Chang J.-Y.;Whang-Peng J.;Hwang T.-L.;Chen L.-T.; Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H. |
| 國立成功大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, J.;Hsieh, R.-K.;Chen, J.-S.;Lee, K.-D.;Rau, K.-M.;Shao, Y.-Y.;Sung, Y.-C.;Yeh, S.-P.;Chang, Chang C.-S.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Yen, C.-J.;Lai, P.-Y.;Hwang, W.-L.;Chiou, T.-J. |
| 國立成功大學 |
2019 |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, W.-C.;Chen, J.-S.;Hung, C.-Y.;Lu, C.-H.;Shao, Y.-Y.;Chiou, T.-J.;Sung, Y.-C.;Rau, K.-M.;Yen, C.-J.;Yeh, S.-P.;Liu, T.-C.;Wu, M.-F.;Lee, M.-Y.;Yu, M.-S.;Hwang, W.-L.;Lai, P.-Y.;Chang, Chang C.-S.;Hsieh, R.-K. |
| 國立成功大學 |
2019 |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, S.-F.;Rau, K.-M.;Shao, Y.-Y.;Yen, C.-J.;Wu, M.-F.;Chen, J.-S.;Chang, Chang C.-S.;Yeh, S.-P.;Chiou, T.-J.;Hsieh, R.-K.;Lee, M.-Y.;Sung, Y.-C.;Lee, K.-D.;Lai, P.-Y.;Yu, M.-S.;Hwang, W.-L.;Liu, T.-C. |
| 臺大學術典藏 |
2018-09-10T15:32:46Z |
The law of Yin and Yang for controlled drugs ecosystem: Maximal analgesia with minimal abuse
|
Sun, W.-Z.;Hsieh, Y.-J.;Lin, C.-S.;Lai, Y.-H.;Chien, S.-C.;Wang, C.-W.;Hsieh, R.-K.; WEI-ZEN SUN |
| 臺大學術典藏 |
2018-09-10T09:52:25Z |
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
|
Agbor-Tarh, D.; Bradbury, I.; Dinh, P.; Baselga, J.; Di Cosimo, S.; Greger Jr.; J.G.; Smith, I.; Jackisch, C.; Kim, S.-B.; Aktas, B.; Huang, C.-S.; Vuylsteke, P.; Hsieh, R.K.; Dreosti, L.; Eidtmann, H.; Piccart, M.; De Azambuja, E.; CHIUN-SHENG HUANG |
